View Post

Yale-led technology receives FDA approval for breast cancer treatment

In In The News by Barbara Jacoby

By: Meg Dalton From: yale.edu More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering research into PROTACs (or PROteolysis TArgeting Chimera), a technology that treats certain types of cancer and other diseases by degrading the proteins that cause them. That company, Arvinas, has since developed a PROTAC therapy called vepdegestrant, …

View Post

Alternative Treatments are Linked to Lower Breast Cancer Survival

In In The News by Barbara Jacoby

By: Stacy Kish From: yale.edu Advances in early screening mammography and new, targeted treatments have reduced overall mortality and recurrence in breast cancer. Yet, despite these advances in traditional treatment options, some patients continue to choose complementary and alternative medicine (CAM), such as dietary supplements, mind and body approaches, and acupuncture. “I was moved by a patient discussing her decision …

View Post

Is Double Mastectomy the Right Choice for You?

In In The News by Barbara Jacoby

BY: KATHY KATELLA From: yalemedicine.org Many younger women who are diagnosed with breast cancer consider having both breasts removed, even when doctors don’t recommend it. Here’s what you need to know to make an informed decision. Receiving a breast cancer diagnosis is overwhelming—the fear, anxiety, and uncertainty can feel unbearable. If you’re facing this situation, you might be wondering, “Should …

View Post

Yale Research Reveals “Biologically Older” Tissue in Patients with Breast Cancer

In In The News by Barbara Jacoby

Source: Yale School of Medicine From: yale.edu An analysis by Yale Cancer Center researchers identified accelerated genetic aging in breast tissue adjacent to breast cancer tumors. Their findings demonstate that adjacent breast tissue is “biologically older” than the chronologic age of the patient, a discovery that may explain why some women develop breast cancer at younger age and may also …

View Post

Lawrence + Memorial Hospital Using Precision Medicine to Treat Breast Cancer

In Clinical Studies News by Barbara Jacoby

Submitted by: Emily Montemerlo From: medicine.yale.edu Yale New Haven Health is bringing precision medicine to breast cancer patients at Lawrence + Memorial Hospital (L+M) with a new imaging agent that is designed specifically to detect certain types of recurrent or metastatic breast cancer. Last year for the first time, the Food and Drug Administration (FDA) approved a Positron Emission Tomography …